The Klinique Medical Clinic Public Company Limited (KLINIQ.BK)
THB 30.0
(0.0%)
THB 30.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.28 Billion | 1.63 Billion | 949.93 Million | 1 Billion | 975.83 Million | 808.41 Million |
| Cost of Revenue | 1.04 Billion | 716.06 Million | 391.16 Million | 406.55 Million | 437.14 Million | 384.81 Million |
| Gross Profit | 1.23 Billion | 922.96 Million | 558.76 Million | 594 Million | 538.69 Million | 423.59 Million |
| Operating Expenses | 889.87 Million | 667.21 Million | 405.52 Million | 425.05 Million | 406.87 Million | 411.58 Million |
| Selling, General and Administrative Expenses | 903.07 Million | 674.27 Million | 407.68 Million | 431.12 Million | 406.87 Million | 411.58 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -13.19 Million | -7.05 Million | -2.15 Million | -6.07 Million | - | - |
| Cost and Expenses | 1.95 Billion | 1.38 Billion | 796.69 Million | 831.61 Million | 844.01 Million | 796.39 Million |
| Operating Income | 331.95 Million | 255.74 Million | 153.24 Million | 168.94 Million | 131.81 Million | 12.01 Million |
| Interest Expense | 15.1 Million | 10.66 Million | 4.31 Million | 5.92 Million | 346.52 Thousand | 220.73 Thousand |
| Income Tax Expense | 61.6 Million | 40.7 Million | 19.72 Million | 20.9 Million | 30.41 Million | -1.88 Million |
| Earnings before Tax | 350.21 Million | 246.19 Million | 148.98 Million | 165.59 Million | 145.87 Million | 14.87 Million |
| Net Income | 288.61 Million | 205.48 Million | 129.25 Million | 144.69 Million | 115.46 Million | 16.76 Million |
| Earnings Per Share Basic | 1.31 | 0.93 | 0.59 | 0.66 | 0.52 | 0.08 |
| Earnings Per Share Diluted | 1.31 | 0.93 | 0.59 | 0.66 | 0.52 | 0.08 |
| Weighted Average Shares Outstanding | 220 Million | 220 Million | 220 Million | 220 Million | 220 Million | 220 Million |
| Weighted Average Shares Outstanding (Diluted) | 220 Million | 220 Million | 220 Million | 220 Million | 220 Million | 220 Million |
| Gross Margin | 0.54 | 0.56 | 0.59 | 0.59 | 0.55 | 0.52 |
| EBIT Margin | 0.20 | 0.24 | 0.25 | 0.25 | 0.21 | 0.09 |
| Profit Margin | 0.13 | 0.13 | 0.14 | 0.14 | 0.12 | 0.02 |
| EBITDA | 450.74 Million | 329 Million | 205.16 Million | 210.04 Million | 220.74 Million | 75.43 Million |
| Earnings Before Tax Margin | 0.15 | 0.16 | 0.16 | 0.17 | 0.14 | 0.01 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 701.6 Million | 687.88 Million | 644.88 Million | 2.28 Billion | 591.44 Million | 539.67 Million |
| Cost of Revenue | 347.19 Million | 341.29 Million | 302.85 Million | 1.04 Billion | 273.18 Million | 243.62 Million |
| Gross Profit | 354.41 Million | 346.58 Million | 342.03 Million | 1.23 Billion | 318.26 Million | 296.04 Million |
| Operating Expenses | 267.44 Million | 257 Million | 262.16 Million | 903.07 Million | 230.04 Million | 211.86 Million |
| Selling, General and Administrative Expenses | 267.44 Million | 257 Million | 262.16 Million | - | 230.49 Million | 214.3 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -1.93 Million | - | - | - | - | - |
| Cost and Expenses | 614.63 Million | 598.3 Million | 565.01 Million | 1.95 Billion | 503.23 Million | 455.49 Million |
| Operating Income | 86.97 Million | 89.57 Million | 79.87 Million | 331.95 Million | 88.21 Million | 84.17 Million |
| Interest Expense | 5.96 Million | 5.44 Million | 4.59 Million | 15.1 Million | 4.07 Million | 3.64 Million |
| Income Tax Expense | 13.73 Million | 14.98 Million | 10.89 Million | 61.6 Million | 18.47 Million | 15.64 Million |
| Earnings before Tax | 87.84 Million | 90.25 Million | 88.85 Million | 350.21 Million | 89.42 Million | 86.29 Million |
| Net Income | 74.11 Million | 75.27 Million | 77.95 Million | 288.61 Million | 70.95 Million | 70.64 Million |
| Earnings Per Share Basic | 0.34 | 0.34 | 0.35 | - | 0.32 | 0.32 |
| Earnings Per Share Diluted | 0.34 | 0.34 | 0.35 | - | 0.32 | 0.32 |
| Weighted Average Shares Outstanding | 220 Million | 220 Million | 220 Million | 220 Million | 220 Million | 220 Million |
| Weighted Average Shares Outstanding (Diluted) | 220 Million | 220 Million | 220 Million | 220 Million | 220 Million | 220 Million |
| Gross Margin | 0.51 | 0.50 | 0.53 | 0.54 | 0.54 | 0.55 |
| EBIT Margin | 0.23 | 0.22 | 0.21 | - | 0.24 | 0.25 |
| Profit Margin | 0.11 | 0.11 | 0.12 | 0.13 | 0.12 | 0.13 |
| EBITDA | 162.2 Million | 151.11 Million | 134.7 Million | - | 143.1 Million | 136.89 Million |
| Earnings Before Tax Margin | 0.12 | 0.13 | 0.12 | 0.15 | 0.15 | 0.16 |
300031
301190
SGRO
PCSA
0SAY
KOHINOOR